Skip to main content

Table 1 Inclusion and exclusion criteria used for article selection in Rayyan

From: The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review

1

Inclusion

Exclusion

2

Articles in English (papers and/or abstracts)

Articles in another language than English (papers and/or abstracts)

3

Peer-reviewed

Registry use not fitting our scope: use of recruitment registry, no use of registries, or use of a registry for other reason than patient pre-screening and selection

4

Use of population registry for trial pre-screening

Prevention clinical trials with healthy individuals

5

Use of patient registry for trial pre-screening

Sole use of healthcare database

6

Use of disease registry for trial pre-screening

Gray literature

7

Clinical trials for patients (not healthy individuals)

Published outside our window 2014–2022

8

Published within our window 2014–2022

Not a clinical trial, or for a trial not yet conducted

9

Abstract available for review

No abstract available

10

High to moderate quality studies, as evaluated through LISA-R

Low quality studies, as evaluated through LISA-R (for phase 3 of study selection)